Pathfinder Therapeutics' Series B Round

Pathfinder Therapeutics raised a round of funding on June 17, 2010.

Pathfinder Therapeutics (PTI) is the developer of Explorer, an image-guided "GPS" device that enables physicians to accurately and efficiently guide the delivery of cancer therapeutics (usually resect…

Articles about Pathfinder Therapeutics' Series B Round: